AHR and breast carcinoma: Aminoflavone, aromatic hydrocarbon receptor ligands, effectively inhibit expression of HIF1A mRNA in breast cancer cells and almost completely block accumulation of the HIF1A protein as well as transcription of downstream target genes in an aromatic hydrocarbon receptor-independent manner [174].